FULCRUM THERAPEUTICS INC (FULC) Stock Analyst Earnings Estimates
NASDAQ:FULC - Nasdaq - US3596161097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.16M 117.23% | 6.34M -66.91% | 2.805M -55.76% | 82.012M 2,823.78% | -100.00% | 23.027M | -100.00% | 4.959M | 26.59M 436.20% | 81.754M 207.46% | 145.32M 77.75% | 193.65M 33.26% | |
| EBITDA YoY % growth | -78.53M -13.43% | -109.72M -39.72% | -108.492M 1.12% | -17.187M 84.16% | -84.538M -391.87% | -65.18M 22.90% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -81.05M -13.18% | -112.13M -38.35% | -110.664M 1.31% | -25.483M 76.97% | -97.461M -282.46% | -113.124M -16.07% | -81.044M 28.36% | -76.895M 5.12% | -56.349M 26.72% | -3.993M 92.91% | 56.042M 1,503.40% | 101.2M 80.58% | |
| Operating Margin | -423.02% | -1,768.61% | -3,945.24% | -31.07% | N/A | -491.27% | N/A | -1,550.61% | -211.92% | -4.88% | 38.56% | 52.26% | |
| EPS YoY % growth | -2.29 18.51% | -2.48 -8.30% | -1.58 36.29% | -0.23 85.47% | -1.33 -481.59% | -1.68 -25.79% | -0.97 41.98% | -0.89 8.38% | -0.61 31.43% | -0.02 96.67% | 0.61 3,100.00% | 1.05 71.67% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 18.04% | -0.37 13.42% | -0.37 -142.50% | -0.38 -9.29% | -0.39 -17.44% |
| Revenue Q2Q % growth | -100.00% | -100.00% | |||
| EBITDA Q2Q % growth | -20.002M 22.53% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.758M 18.70% | -25.119M 15.80% | -25.086M -147.79% | -26.021M -12.83% | -25.988M -14.19% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.35 10.26% | -0.41 | 0.06 | 15.39% |
| Q2 2024 Q2Q % growth | 0.87 328.95% | -0.01 | 0.88 | 6,923.53% |
| Q1 2024 Q2Q % growth | -0.43 -4.88% | -0.45 | 0.02 | 3.64% |
| Q4 2023 Q2Q % growth | -0.40 20.00% | -0.43 | 0.03 | 7.88% |
| Q3 2023 Q2Q % growth | -0.39 23.53% | -0.44 | 0.05 | 12.10% |
| Q2 2023 Q2Q % growth | -0.38 54.22% | -0.45 | 0.07 | 16.20% |
| Q1 2023 Q2Q % growth | -0.41 35.94% | -0.46 | 0.05 | 11.75% |
| Q4 2022 Q2Q % growth | -0.50 13.79% | -0.50 | 0.00 | -0.06% |
| Q3 2022 Q2Q % growth | -0.51 10.53% | -0.62 | 0.11 | 18.32% |
| Q2 2022 Q2Q % growth | -0.83 -38.33% | -0.67 | -0.16 | -23.17% |
| Q1 2022 Q2Q % growth | -0.64 -18.52% | -0.64 | 0.00 | -0.11% |
| Q4 2021 Q2Q % growth | -0.58 9.38% | -0.74 | 0.16 | 21.83% |
| Q3 2021 Q2Q % growth | -0.57 18.57% | -0.66 | 0.09 | 13.59% |
| Q2 2021 Q2Q % growth | -0.60 9.09% | -0.64 | 0.04 | 5.81% |
| Q1 2021 Q2Q % growth | -0.54 33.33% | -0.67 | 0.13 | 19.42% |
| Q4 2020 Q2Q % growth | -0.64 9.86% | -0.74 | 0.10 | 13.46% |
| Q3 2020 Q2Q % growth | -0.70 27.84% | -0.67 | -0.03 | -5.04% |
| Q2 2020 Q2Q % growth | -0.66 92.83% | -0.79 | 0.13 | 16.62% |
| Q1 2020 Q2Q % growth | -0.81 | -0.77 | -0.04 | -5.41% |
| Q4 2019 Q2Q % growth | -0.71 | -0.85 | 0.14 | 16.64% |
| Q3 2019 Q2Q % growth | -0.97 | -3.04 | 2.07 | 68.06% |
| Q2 2019 Q2Q % growth | -9.21 | -3.16 | -6.05 | -191.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | 80M 8,990.91% | 37.276M | 42.724M | 114.62% |
| Q1 2024 Q2Q % growth | -100.00% | 367.343K | -367.343K | -100.00% |
| Q4 2023 Q2Q % growth | 871K 26.23% | 470.393K | 400.607K | 85.16% |
| Q3 2023 Q2Q % growth | 759K -35.68% | 1.073M | -314K | -29.26% |
| Q2 2023 Q2Q % growth | 880K -53.19% | 1.138M | -258K | -22.67% |
| Q1 2023 Q2Q % growth | 295K -88.61% | 1.15M | -855K | -74.35% |
| Q4 2022 Q2Q % growth | 690K -86.36% | 1.687M | -997K | -59.10% |
| Q3 2022 Q2Q % growth | 1.18M -76.11% | 2.594M | -1.414M | -54.51% |
| Q2 2022 Q2Q % growth | 1.88M -57.08% | 3.024M | -1.144M | -37.83% |
| Q1 2022 Q2Q % growth | 2.59M -45.93% | 4.023M | -1.433M | -35.62% |
| Q4 2021 Q2Q % growth | 5.06M 19.62% | 2.733M | 2.327M | 85.14% |
| Q3 2021 Q2Q % growth | 4.94M 167.03% | 2.295M | 2.645M | 115.25% |
| Q2 2021 Q2Q % growth | 4.38M 119.00% | 1.629M | 2.751M | 168.88% |
| Q1 2021 Q2Q % growth | 4.79M 538.67% | 1.454M | 3.336M | 229.44% |
| Q4 2020 Q2Q % growth | 4.23M | 1.332M | 2.898M | 217.57% |
| Q3 2020 Q2Q % growth | 1.85M | 561K | 1.289M | 229.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.22% | 28.97% | -3.62% | 19.32% |
| Revenue | N/A | -100% | 0.06% | 0.06% |